Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway

References

• VallhovHGabrielssonSStrømmeMScheyniusAGarcia-BennettAEMesoporous silica particles induce size dependent effects on human dendritic cellsNano Lett20077123576358217975942
   PubMed Web of Science ®Google Scholar
• ChungTHWuSHYaoMThe effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cellsBiomaterials200728192959296617397919
   PubMed Web of Science ®Google Scholar
• CarinoISPasquaLTestaFSilica-based mesoporous materials as drug delivery system for methotrexate releaseDrug Deliv200714849149518027178
   PubMed Web of Science ®Google Scholar
• GuJFanWShimojimaAOkuboTOrganic-inorganic mesoporous nanocarriers integrated with biogenic ligandsSmall20073101740174417786917
   PubMed Web of Science ®Google Scholar
• YunHSParkJWKimSHKimYJJangJHEffect of the pore structure of bioactive glass balls on biocompatibility in vitro and in vivoActa Biomater2011762651266021320647
   PubMed Web of Science ®Google Scholar
• CainelliFTankoMNVentoSVento, Silica exposure and silicosis: action is needed nowSouth Med J201010311107820856176
   PubMed Web of Science ®Google Scholar
• DeMuthPHurleyMWuCMesoscale porous silica as drug delivery vehicles: Synthesis, characterization, and pH-sensitive release profilesMicroporous and Mesoporous Materials20111411128134
   Web of Science ®Google Scholar
• YuanLTangQYangDZhangJZZhangFHuJPreparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug deliveryThe Journal of Physical Chemistry C2011115207
   Web of Science ®Google Scholar
• WangTChaiFFuQUniform hollow mesoporous silica nanocages for drug delivery in vitroand in vivo for liver cancer therapyJournal of Materials Chemistry2011211452995306
   Web of Science ®Google Scholar
• HeQShiJMesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibilityJournal of Materials Chemistry2011211658455855
   Web of Science ®Google Scholar
• LeeSYunHSKimSHThe comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosisBiomaterials201132359434944321889200
   PubMed Web of Science ®Google Scholar
• LuJLiongMLiZZinkJITamanoiFBiocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in AnimalsSmall20106161794180520623530
   PubMed Web of Science ®Google Scholar
• YuTGreishKMcGillLDRayAGhandehariHInfluence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance thresholdACS Nano2012632289230122364198
   PubMed Web of Science ®Google Scholar
• WangFGaoFLanMYuanHHuangYLiuJOxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cellsToxicol In Vitro200923580881519401228
   PubMed Web of Science ®Google Scholar
• PassagneIMorilleMRoussetMPujaltéIL’azouBImplication of oxidative stress in size-dependent toxicity of silica nanoparticles in kidney cellsToxicology20122992–311212422627296
   PubMed Web of Science ®Google Scholar
• KarinMBen-NeriahYPhosphorylation meets ubiquitination: the control of NF-[kappa]B activityAnnu Rev Immunol20001862166310837071
   PubMed Web of Science ®Google Scholar
• BierhausASchiekoferSSchwaningerMDiabetes-associated sustained activation of the transcription factor nuclear factor-kappaBDiabetes200150122792280811723063
   PubMed Web of Science ®Google Scholar
• RialNSChoiKNguyenTSnyderBSlepianMJNuclear factor kappaB (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?Med Hypotheses2012781293222014759
   PubMed Web of Science ®Google Scholar
• SchmidHBoucherotAYasudaYModular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathyDiabetes200655112993300317065335
   PubMed Web of Science ®Google Scholar
• LiLTangFLiuHIn vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacyACS Nano20104116874688220973487
   PubMed Web of Science ®Google Scholar
• LuJLiongMZinkJITamanoiFMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall2007381341134617566138
   PubMed Web of Science ®Google Scholar
• WangQXXiangYCuiYLLinKMZhangXFDietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2expression via the NF-κB inactivationPLoS One201273e3411222457817
   PubMed Web of Science ®Google Scholar
• ZhangJYJinHWangGFMethyl-1-hydroxy-2-naphthoate, a novel naphthol derivative, inhibits lipopolysaccharide-induced inflammatory response in macrophages via suppression of NF-κB, JNK and p38 MAPK pathwaysInflamm Res201160985185921667204
   PubMed Web of Science ®Google Scholar
• WangLYWangHYOuyangJLow concentration of lipopolysaccharide acts on MC3T3-E1 osteoblasts and induces proliferation via the COX-2-independent NFkappaB pathwayCell Biochem Funct200927423824219384903
   PubMed Web of Science ®Google Scholar
• LiuHChenDLiLMultifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicityAngew Chem Int Ed Engl201150489189521246685
   PubMed Web of Science ®Google Scholar
• HamiltonRFJrThakurSAMayfairJKHolianAMARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 miceJ Biol Chem20062814534218342616984918
   PubMed Web of Science ®Google Scholar
• SlowingIIVivero-EscotoJLWuCWLinVSMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Deliv Rev200860111278128818514969
   PubMed Web of Science ®Google Scholar
• SlowingIIWuCWVivero-EscotoJLLinVSMesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cellsSmall200951576219051185
   PubMed Web of Science ®Google Scholar
• TaoZMorrowMPAsefaTMesoporous silica nanoparticles inhibit cellular respirationNano Lett2008851517152618376867
   PubMed Web of Science ®Google Scholar
• BellusciMLa BarberaAPadellaFBiodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical processInt J Nanomedicine201491919192924790434
   PubMed Web of Science ®Google Scholar
• MancusoLCaoGAcute toxicity test of CuO nanoparticles using human mesenchymal stem cellsToxicol Mech Methods201424744955424861541
   PubMed Web of Science ®Google Scholar
• LorkeDA new approach to practical acute toxicity testingArch Toxicol19835442752876667118
   PubMed Web of Science ®Google Scholar
• International conference on harmonisationICH guidance on toxicokinetics: the assessment of systemic exposure in toxicity studies s3a1994 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S3A/Step4/S3A_Guideline.pdfAccessed November 15, 2014
   Google Scholar
• The Organisation for Economic Co-operation and DevelopmentOECD guidelines for the testing of the chemicals-draft proposal for a revised TG 417: Toxicokinetics2008 Available from: http://www.oecd.org/chemicalsafety/testing/41690691.pdfAccessed November 15, 2014
   Google Scholar
• United States Food and Drug AdministrationM3(R2) nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals2010 Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073246.pdfAccessed November 15, 2014
   Google Scholar
• United States Food and Drug AdministrationGuidance for industry, developing medical imaging drug and biological products, part 1: conducting safety assessments2004 Available from: http://www.fda.gov/downloads/Drugs/…/Guidances/ucm071600.pdfAccessed November 15, 2014
   Google Scholar
• KanakiaSToussaintJDMullick ChowdhurySDose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulationsBiomaterials201435257022703124854092
   PubMed Web of Science ®Google Scholar
• EddyAAMolecular basis of renal fibrosisPediatr Nephrol2000153–429030111149129
   PubMed Web of Science ®Google Scholar
• LeungKCTonelliMJamesMTChronic kidney disease following acute kidney injury-risk and outcomesNat Rev Nephrol201392778523247572
   PubMed Web of Science ®Google Scholar
• SourisJSLeeCHChengSHSurface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticlesBiomaterials201031215564557420417962
   PubMed Web of Science ®Google Scholar
• NabeshiHYoshikawaTMatsuyamaKSystemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical applicationBiomaterials201132112713272421262533
   PubMed Web of Science ®Google Scholar
• NabeshiHYoshikawaTMatsuyamaKAmorphous nanosilicas induce consumptive coagulopathy after systemic exposureNanotechnology201223404510122214761
   PubMed Web of Science ®Google Scholar
• YoshidaTYoshiokaYTochigiSIntranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in micePart Fibre Toxicol2013104123958113
   PubMed Web of Science ®Google Scholar
• LiuTLiLFuCLiuHChenDTangFPathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticlesBiomaterials20123372399240722182752
   PubMed Web of Science ®Google Scholar
• TaoZTomsBBGoodismanJAsefaTMesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterialsChem Res Toxicol200922111869188019817448
   PubMed Web of Science ®Google Scholar
• SunWFangNTrewynBGEndocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopyAnal Bioanal Chem200839162119212518488205
   PubMed Web of Science ®Google Scholar
• HarrisonJChenJQMillerWRisk of silicosis in cohorts of Chinese tin and tungsten miners and pottery workers (II): Workplace-specific silica particle surface compositionAm J Ind Med2005481101515940714
   PubMed Web of Science ®Google Scholar
• MundtKABirkTParsonsWRespirable crystalline silica exposure-response evaluation of silicosis morbidity and lung cancer mortality in the German porcelain industry cohortJ Occup Environ Med201153328228921346639
   PubMed Web of Science ®Google Scholar
• MühlfeldCGehrPRothen-RutishauserBTranslocation and cellular entering mechanisms of nanoparticles in the respiratory tractSwiss Med Wkly200813827–2838739118642134
   PubMed Web of Science ®Google Scholar
• OberdörsterGOberdörsterEOberdörsterJNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesEnviron Health Perspect2005113782383916002369
   PubMed Web of Science ®Google Scholar
• GuijarroCEgidoJTranscription factor-kappaB (NF-kappaB) and renal diseaseKidney Int200159241542411168923
   PubMed Web of Science ®Google Scholar
• BitzerMvon GersdorffGLiangDA mechanism of suppression of TGF-beta/SMAD signaling by NF-kappaB/RelAGenes Dev200014218719710652273
   PubMed Web of Science ®Google Scholar
• ChenLZhangJZhangYWangYWangBImprovement of inflammatory responses associated with NF-kappaB pathway in kidneys from diabetic ratsInflamm Res200857519920418465086
   PubMed Web of Science ®Google Scholar
• GhiazzaMPolimeniMFenoglioIGazzanoEGhigoDFubiniBDoes vitreous silica contradict the toxicity of the crystalline silica paradigm?Chem Res Toxicol201023362062920085295
   PubMed Web of Science ®Google Scholar
• KangJLJungHJLeeKKimHRSrc tyrosine kinases mediate crystalline silica-induced NF-kappaB activation through tyrosine phosphorylation of IkappaB-alpha and p65 NF-kappaB in RAW 264.7 macrophagesToxicol Sci200690247047716431847
   PubMed Web of Science ®Google Scholar
• MirzaALiuSLFrizellEA role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaBAm J Physiol19972722 Pt 1G281G2889124352
   PubMedGoogle Scholar
• Bondar’IAKlimontovVVNadeevAPUrinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathyTer Arkh20088015256 Russian18326229
   PubMed Web of Science ®Google Scholar
• IwamotoMMizuiriSAritaMHemmiHNuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathyTohoku J Exp Med2005206216317115888973
   PubMed Web of Science ®Google Scholar
• MezzanoSArosCDroguettANF-kappaB activation and overexpression of regulated genes in human diabetic nephropathyNephrol Dial Transplant200419102505251215280531
   PubMed Web of Science ®Google Scholar
• HuangXZhuangJTengXThe promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen speciesBiomaterials201031246142215320510446
   PubMed Web of Science ®Google Scholar
• HuangXTengXChenDTangFHeJThe effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell functionBiomaterials201031343844819800115
   PubMed Web of Science ®Google Scholar
• AngelosSLLiongMChoiEZinkJIMesoporous silicate materials as substrates for molecular machines and drug deliveryChemical Engineering Journal2008137413
   Web of Science ®Google Scholar
• HuangXZhuangJChenDGeneral strategy for designing functionalized magnetic microspheres for different bioapplicationsLangmuir20092519116571166319694417
   PubMed Web of Science ®Google Scholar